EUVIMEDEUVIMED entdecken
Crossref

Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy

Shaozong Qin, Chi Liu, Yin Chen, Mengying Yao, Shuyi Liao, Wang Xin, Shuiqin Gong, Xu Guan, Yan Li, Jiachuan Xiong, Jing Chen, Yunzhu Shen und 3 weitere

Kidney International · 2023-05 · 103 (5) · 903-916

DOI: 10.1016/j.kint.2023.01.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2023-05. Verfasst von Shaozong Qin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Cen…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Acute Kidney Injury. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, Army Medical University Xinqiao Hospital, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating evidence highlights mitochondrial dysfunction as a crucial factor in the pathogenesis of acute kidney injury (AKI); thus, novel therapeutic strategies maintaining mitochondrial homeostasis are highly anticipated. Recent studies have shown that cobaltosic oxide has peroxidase-like catalytic activities, although its role and mechanism remain elusive in AKI. In the present study, we synthesized and identified cobaltosic oxide-polyethylene glycol-triphenylphosphine (COPT) nanoparticles by conjugating cobaltosic oxide with polyethylene glycol and triphenylphosphine, to improve its biocompatibility and mitochondria-targeting property. We found that COPT preferentially accumulated in the kidney proximal tubule cells, and significantly alleviated ischemic AKI in mouse models and gentamicin induced-AKI in the zebrafish model. COPT also inhibited the transition from AKI to chronic kidney disease (CKD), with few side effects. Further studies demonstrated that COPT localized in the mitochondria, and ameliorated hypoxia-reoxygenation-mediated mitochondrial damage through enhancing mitophagy in vitro and in vivo. Mechanistically, COPT dose-dependently induced the expression of Bcl-2/adenovirus E1B 19-kDa interacting protein (BNIP3), while knockdown of BNIP3 attenuated COPT-induced mitophagic flux and mitochondrial protection. Thus, our findings suggest that COPT nanoparticles ameliorate AKI and its progression to CKD through inducing BNIP3-mediated mitophagy, indicating that COPT may serve as a promising mitochondria-targeting therapeutic agent against AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicAcute Kidney InjuryMiceAnimalsMitophagyZebrafishMitochondrial ProteinsMembrane ProteinsOrganophosphorus Compounds

Stichwörter der Autor:innen

BNIP3COPTacute kidney injurychronic kidney diseasemitophagy

Substanzen

Mitochondrial ProteinsMembrane ProteinstriphenylphosphineOrganophosphorus CompoundsBNip3 protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical Uni…
  • Institute of Combined Injury, State Key Laboratory of Trauma, Burns and Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University (Third Military Me…

Förderung

  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Army Medical University Xinqiao Hospital
  • National Natural Science Foundation of China
  • Natural Science Foundation Project of Chongqing
  • Chongqing Science and Technology Commission
  • Army Medical University
  • National Key Research and Development Program of China

Zitieren

APA

Qin, S., Liu, C., Chen, Y., Yao, M., Liao, S., Xin, W., Gong, S., Guan, X., Li, Y., Xiong, J., Chen, J., Shen, Y., Liu, Y., Zhao, J., & Huang, Y. (2023). Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy. Kidney International, 103(5), 903-916. https://doi.org/10.1016/j.kint.2023.01.025

Vancouver

Qin S, Liu C, Chen Y, Yao M, Liao S, Xin W, et al. Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy. Kidney International. 2023;103(5):903-916. doi:10.1016/j.kint.2023.01.025

BibTeX
@article{Qin2023,
  author = {Qin, Shaozong and Liu, Chi and Chen, Yin and Yao, Mengying and Liao, Shuyi and Xin, Wang and Gong, Shuiqin and Guan, Xu and Li, Yan and Xiong, Jiachuan and Chen, Jing and Shen, Yunzhu and Liu, Yong and Zhao, Jinghong and Huang, Yinghui},
  title = {Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy},
  journal = {Kidney International},
  year = {2023},
  volume = {103},
  number = {5},
  pages = {903--916},
  doi = {10.1016/j.kint.2023.01.025}
}
Kostenlos starten →